Antipsychotic prescribing trends for autistic adults with and without intellectual disability from 1997 to 2023: a population-based cohort study using English primary care records.

Aws A S Sadik, Golam Khandaker, Antonio Pardinas, Dheeraj Rai, Paul C Madley-Dowd

Research output: Contribution to conference › Conference Poster

6 Downloads (Pure)

Abstract

Concerns around antipsychotic over-prescribing for autistic adults has led to deprescribing initiatives, including NHS England’s “Stopping the overmedication of people with intellectual disability, autism, or both” (STOMP) in 2015. So, how have prescribing rates, indication recording, doses, and long-term prescribing changed over time?
Original languageEnglish
Publication statusPublished - 23 Jun 2025
EventRoyal College of Psychiatrists International Congress 2025 -
Duration: 23 Jun 2025 → 26 Jun 2025

Conference

ConferenceRoyal College of Psychiatrists International Congress 2025
Period23/06/25 → 26/06/25

Research Groups and Themes

  • Bristol Population Health Science Institute

Access to Document

Handle.net

    Fingerprint

    Dive into the research topics of 'Antipsychotic prescribing trends for autistic adults with and without intellectual disability from 1997 to 2023: a population-based cohort study using English primary care records.'. Together they form a unique fingerprint.
    View full fingerprint

    • Integrative Epidemiology Unit

      Khandaker, G. (Principal Investigator)

      1/04/23 → 31/03/28

      Project: Research

    Cite this